Why is Mankind Pharma falling/rising?

As of 16-Jul, Mankind Pharma Ltd's stock price is currently at 2,623.55, reflecting a decrease of 28.65 points or 1.08%. The stock has been underperforming recently, having fallen for the last two days, resulting in a total decline of 2.82% during this period. Despite this, Mankind Pharma is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating some underlying strength. The stock has generated a notable return of 23.90% over the past year, significantly outperforming the broader market, which has only returned 0.47%. However, there has been a marked decline in investor participation, with delivery volume dropping by 55.59% compared to the 5-day average, which may indicate waning interest among investors.
In the broader market context, Mankind Pharma's recent performance contrasts with the Sensex, which has seen a decline of 1.08% over the past week. While the stock has shown strong long-term growth potential, evidenced by a high return on equity of 19.25% and a healthy operating profit growth rate of 23.44%, the recent price movement suggests that short-term pressures are affecting investor sentiment. The high institutional holdings at 24.4% may provide some stability, as these investors typically have more resources to analyze the company's fundamentals. Nonetheless, the combination of declining delivery volumes and consecutive price falls indicates that the stock is currently facing challenges that are impacting its price negatively.